Determining the estimated date of delivery following in vitro fertilization (IVF) relies on the precise timing of the embryo transfer. Unlike natural conception where the date of ovulation needs to be estimated, IVF provides exact knowledge of the embryo’s age. The calculation typically involves adding 266 days (38 weeks) to the date of egg retrieval or 261 days to the date of fertilization. This method accounts for the fact that fertilization occurs outside the body and allows for a more accurate assessment of gestational age compared to calculations based on the last menstrual period.
Accurate dating in IVF pregnancies is crucial for several reasons. It allows healthcare providers to monitor fetal development appropriately, schedule necessary prenatal screenings and tests at the optimal times, and plan for delivery with greater precision. Furthermore, because IVF pregnancies can sometimes have a higher risk of complications, knowing the precise gestational age aids in timely interventions if needed. This precision also contributes to informed decision-making regarding potential interventions, such as induction of labor.
Understanding the methods used for establishing the anticipated delivery date after IVF sets the stage for a deeper exploration of the specific steps involved in the calculation, potential variations based on embryo transfer timing (e.g., day 3 or day 5 transfers), and the importance of ultrasound confirmation to refine this initial estimate. Furthermore, factors that might influence the reliability of these calculations warrant discussion.
1. Egg Retrieval Date
The egg retrieval date serves as a foundational element in determining the estimated due date following in vitro fertilization. Because IVF bypasses natural ovulation, the precise day of egg retrieval is known, providing a defined starting point for calculating gestational age. This date is analogous to the date of ovulation in spontaneous conceptions, but with increased certainty. The established protocol involves adding 266 days (38 weeks) to the retrieval date, arriving at the anticipated delivery date. This calculation assumes that fertilization occurs on the same day as retrieval or shortly thereafter.
For instance, if egg retrieval occurs on March 1st, the initial estimated due date would be approximately December 22nd. However, this is a preliminary estimate. The embryo transfer day, specifically whether it is a Day 3 or Day 5 transfer, influences the final calculation. After a Day 3 transfer, 263 days are added to the retrieval date, and after a Day 5 transfer, 261 days are added. Early ultrasound measurements will further refine this estimate, ensuring accurate monitoring of fetal growth and development. Any discrepancy between the due date calculated from the egg retrieval date and that based on early ultrasound is carefully evaluated by the physician to determine the most accurate gestational age.
In summary, the egg retrieval date initiates the process of establishing the due date in IVF. It provides a precise point of reference that, when combined with the timing of embryo transfer and confirmed by early ultrasound, allows for accurate gestational age assessment. This accuracy is vital for optimizing prenatal care, scheduling appropriate screening tests, and preparing for delivery. Despite the initial precision offered by the retrieval date, acknowledging the potential for variations based on embryo development and individual patient factors ensures comprehensive and personalized obstetric management.
2. Embryo Transfer Day
The embryo transfer day critically impacts the accurate determination of the estimated delivery date in IVF. The age of the embryo at the time of transfer necessitates adjustments to the standard calculation. If the embryo is transferred on Day 3 (three days after egg retrieval), the due date calculation requires adding 263 days to the retrieval date. Conversely, a Day 5 transfer (blastocyst stage) requires adding 261 days to the retrieval date. Failure to account for the embryo’s age during transfer will result in an inaccurate due date estimate, potentially affecting the timing of prenatal screenings, the interpretation of fetal growth assessments, and ultimately, decisions related to delivery management.
For instance, consider two patients undergoing IVF, both with egg retrieval on April 1st. Patient A undergoes a Day 3 transfer on April 4th. The initial due date estimation based solely on the retrieval date (April 1st + 266 days) would be December 23rd. However, factoring in the Day 3 transfer, the calculation becomes April 1st + 263 days, resulting in a more accurate due date of December 20th. Patient B has a Day 5 transfer on April 6th. Her adjusted due date becomes April 1st + 261 days, resulting in a due date of December 18th. These seemingly small differences can be significant in managing pregnancy and planning interventions if needed.
In summary, the embryo transfer day is an indispensable variable in calculating the estimated delivery date in IVF. Accurate dating is a cornerstone of appropriate obstetric care. Overlooking this factor introduces error, with potential ramifications for patient management and outcomes. Early ultrasound confirmation remains vital to refine the initial due date estimation, but the consideration of the embryo transfer day provides a crucial foundation for precise gestational age assessment.
3. Gestational Age at Transfer
Gestational age at transfer is a critical parameter in determining the estimated delivery date following in vitro fertilization (IVF). This parameter defines the age of the embryo when it is transferred into the uterus, directly influencing the calculation of the due date. The precise knowledge of gestational age at transfer, coupled with the egg retrieval date, enables a more accurate prediction compared to estimations based solely on the last menstrual period, as is common in natural conceptions.
-
Impact on Calculation Precision
The gestational age at transfer, whether Day 3 or Day 5, dictates the number of days added to the egg retrieval date to estimate the due date. A Day 3 transfer requires adding 263 days, while a Day 5 transfer necessitates adding 261 days. The selection of the appropriate number ensures a more precise initial due date calculation. Failure to account for the embryo’s age leads to a discrepancy, potentially influencing the timing of prenatal screenings and interventions.
-
Influence on Ultrasound Accuracy
While the gestational age at transfer establishes a foundation, early ultrasound measurements are crucial for refining the estimated due date. Discrepancies between the calculated date and ultrasound measurements necessitate careful evaluation. Significant deviations may indicate variations in embryo development or potential inaccuracies in the initial dating. The sonographic assessment, therefore, acts as a validating tool, ensuring alignment between the embryo’s developmental milestones and the calculated gestational age.
-
Relevance to Obstetric Management
An accurate estimation of gestational age is paramount for appropriate obstetric management. It informs the timing of critical prenatal assessments, such as genetic screening and anatomy scans. Moreover, it guides decisions regarding potential interventions in cases of complications, such as preterm labor or post-term pregnancy. A miscalculated due date can lead to premature or delayed interventions, impacting maternal and neonatal outcomes.
-
Relationship to Embryo Development
The decision to transfer embryos on Day 3 versus Day 5 often reflects an assessment of embryo quality and developmental potential. Day 5 transfer, involving blastocyst stage embryos, typically indicates greater developmental competence. While the transfer day alters the due date calculation, it also indirectly reflects the health and viability of the embryo. This interplay between transfer timing, embryo development, and accurate dating is essential for optimizing IVF pregnancy outcomes.
In conclusion, the gestational age at transfer is not merely a variable in a calculation; it represents a critical point in the timeline of an IVF pregnancy. Its integration into the due date estimation, combined with the egg retrieval date and refined by early ultrasound, allows for precise gestational age assessment. This precision is crucial for appropriate obstetric care, timely interventions, and ultimately, improved maternal and neonatal well-being in IVF pregnancies.
4. 266 Days (38 Weeks)
The figure of 266 days (38 weeks) constitutes the cornerstone of estimated delivery date calculations in in vitro fertilization (IVF). This duration represents the average time from fertilization to the onset of spontaneous labor in human pregnancies. In the context of IVF, where the exact date of fertilization or a close approximation (egg retrieval date) is known, adding 266 days provides an initial estimate of the due date. This method contrasts with natural conception, where calculations are often based on the last menstrual period, a less precise marker due to variations in ovulation timing. For example, if egg retrieval occurs on January 1st, adding 266 days yields an initial estimated due date in early October. The certainty afforded by knowing the retrieval date underscores the reliance on the 266-day baseline in IVF dating.
The 266-day parameter, however, serves as a starting point. Further refinements are necessary, based on the day of embryo transfer. Transferring an embryo on Day 3 post-retrieval necessitates adjusting the calculation by adding 263 days to the retrieval date. Similarly, a Day 5 transfer (blastocyst stage) requires adding 261 days. These adjustments account for the time the embryo spent developing in vitro. Without these corrections, the estimated delivery date would be inaccurate. This accuracy is vital for timing prenatal screenings and preparing for potential delivery interventions. As an illustrative case, consider a patient with egg retrieval on March 10th and a Day 5 transfer. The adjusted calculation is March 10th plus 261 days, resulting in a due date in late November, differing slightly from the initial 266-day calculation.
In conclusion, while 266 days (38 weeks) establishes the fundamental timeframe for estimating delivery dates in IVF, its application requires careful consideration of the embryo transfer day. Accurate integration of these factors, coupled with ultrasound confirmations, is essential for precise dating. Challenges arise when early ultrasounds reveal discrepancies, requiring careful clinical judgment to reconcile the differences. The precise knowledge of the fertilization date and the embryo’s developmental stage provided by IVF makes the ‘266 days’ rule a more reliable method than LMP calculations, offering significant benefits in managing these pregnancies.
5. Early Ultrasound
Early ultrasound examination serves as a critical validation tool in establishing the estimated delivery date following in vitro fertilization (IVF). While the egg retrieval date and embryo transfer day provide a foundational framework for calculating gestational age, early ultrasound findings can either confirm the accuracy of this initial estimation or necessitate adjustments. The ultrasound, typically performed between 6 and 10 weeks of gestation, allows for direct visualization and measurement of the developing embryo or fetus. Crown-rump length (CRL), the measurement from the top of the head to the bottom of the buttocks, is then used to determine gestational age. For example, an ultrasound performed at what is calculated to be 8 weeks of gestation, based on retrieval and transfer dates, might reveal a CRL consistent with 8 weeks and 2 days. In such a case, the due date would be adjusted accordingly, refining the initial IVF-based estimation.
The importance of early ultrasound stems from its ability to detect discrepancies between the calculated gestational age and the actual fetal development. These discrepancies might arise from variations in embryo growth rates or errors in recalling dates if relying on a menstrual period. The degree of deviation considered clinically significant varies, but generally, a difference of more than 5-7 days in the first trimester warrants adjusting the estimated delivery date. This adjustment ensures that subsequent prenatal screenings, such as nuchal translucency measurement for Down syndrome risk assessment, are performed at the optimal gestational age. Similarly, management of potential pregnancy complications, such as preterm labor or post-term pregnancy, hinges on accurate dating. Without early ultrasound confirmation, reliance solely on IVF dates could lead to miscalculated gestational age, impacting the timing and appropriateness of these interventions. Consider a scenario where IVF dates suggest 39 weeks of gestation, but an early ultrasound-adjusted date indicates only 38 weeks. Induction of labor at the IVF-calculated 40 weeks might result in delivering a fetus that is actually closer to 39 weeks, potentially increasing the risk of neonatal complications.
In summary, early ultrasound plays a pivotal role in refining the estimated delivery date established through IVF. It provides a direct assessment of fetal development, allowing for the detection and correction of any discrepancies. By validating or adjusting the initial IVF-based calculation, early ultrasound ensures accurate gestational age assessment, optimizing the timing of prenatal care and informing critical decisions regarding pregnancy management. The integration of early ultrasound into the process of “how to calculate due date in IVF” reflects a commitment to maximizing the precision and effectiveness of obstetric care in these pregnancies. While retrieval and transfer dates provide a strong starting point, only early ultrasound can ground these numbers in the reality of the developing fetus.
6. Fetal Development Monitoring
Fetal development monitoring plays a crucial role in pregnancies achieved through in vitro fertilization (IVF), where the estimated delivery date is calculated with a higher degree of precision. Given the controlled environment of conception and transfer in IVF, adherence to expected developmental milestones is closely scrutinized. Monitoring techniques and their interpretation are intrinsically linked to the accuracy of the calculated due date, providing essential feedback on fetal well-being.
-
Ultrasound Assessments of Growth
Serial ultrasound examinations are fundamental for assessing fetal growth parameters such as biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL). These measurements are compared to established growth charts for gestational age. If the fetal measurements consistently deviate from what is expected based on the calculated due date, further investigation may be warranted to rule out growth restriction or macrosomia. For instance, consistently small measurements may prompt evaluation for placental insufficiency, while large measurements may suggest gestational diabetes.
-
Doppler Studies of Fetal Circulation
Doppler ultrasound assesses blood flow velocity in fetal vessels, such as the umbilical artery and middle cerebral artery. Abnormal Doppler findings, such as increased resistance in the umbilical artery, can indicate placental dysfunction and fetal compromise. These findings must be interpreted within the context of the calculated due date. A finding that might be concerning at 32 weeks may be less so at 38 weeks, highlighting the importance of accurate dating.
-
Amniotic Fluid Volume Assessment
Amniotic fluid volume is an indicator of fetal well-being and kidney function. Oligohydramnios (low amniotic fluid) can be associated with fetal growth restriction or placental insufficiency. Polyhydramnios (excess amniotic fluid) may be linked to fetal anomalies or maternal diabetes. Assessing amniotic fluid volume is more meaningful when correlated with the expected gestational age, derived from the IVF due date calculation. Unexpectedly low fluid at term, for instance, may prompt immediate delivery.
-
Fetal Movement Counting
Maternal perception of fetal movements is a simple yet valuable assessment of fetal well-being. Decreased fetal movement can be a sign of fetal distress. While subjective, a significant and persistent decrease in fetal movement warrants further investigation. The expected pattern of fetal movement changes with gestational age; hence, an accurate due date is necessary for appropriate interpretation of fetal movement patterns. Less robust movement may be expected earlier in the third trimester than closer to term.
In conclusion, fetal development monitoring is inextricably linked to the accuracy of the calculated due date in IVF pregnancies. The interpretation of ultrasound measurements, Doppler studies, amniotic fluid volume, and fetal movement patterns relies heavily on knowing the precise gestational age. Discrepancies between expected development and actual findings necessitate a thorough evaluation, underscoring the importance of accurate dating for optimal obstetric management and fetal outcomes. Without precise dating, monitoring efforts are severely compromised and can lead to inappropriate interventions.
7. Prematurity Risk Assessment
Prematurity risk assessment is integrally linked to how the estimated date of delivery is calculated in in vitro fertilization (IVF). While IVF provides a more precise conception date compared to natural pregnancies, this precision is paramount in identifying and mitigating the risks associated with preterm birth. Accurate determination of gestational age allows healthcare providers to monitor pregnancies closely and implement timely interventions aimed at reducing the likelihood and consequences of prematurity. For example, if the estimated date is miscalculated by even a week, interventions such as administering corticosteroids to enhance fetal lung maturation might be given too early or too late, reducing their effectiveness.
Prematurity risk assessment within the context of IVF necessitates a multifaceted approach that considers both maternal and fetal factors. Maternal risk factors may include a history of prior preterm birth, multiple gestations, and certain medical conditions. Fetal factors encompass growth abnormalities detected via ultrasound and biophysical profile assessments. Accurate dating ensures that these assessments are conducted at the appropriate gestational age, maximizing their predictive value. Consider a patient with a history of cervical insufficiency undergoing IVF. Accurate gestational dating is crucial for the timing of cervical cerclage placement, a procedure aimed at preventing preterm labor. Placing the cerclage too early may increase the risk of complications, while delaying the procedure may render it ineffective.
In conclusion, the accurate calculation of the estimated delivery date in IVF is not merely an academic exercise but a clinically significant factor in prematurity risk assessment. The ability to precisely date an IVF pregnancy allows for timely and targeted interventions, contributing to improved neonatal outcomes. Challenges remain in managing complex cases, but the initial precision afforded by IVF dating provides a solid foundation for optimizing prenatal care and minimizing the risks associated with preterm birth. Ongoing research continues to refine strategies for prematurity prevention in IVF pregnancies, building upon the bedrock of accurate gestational age assessment.
8. Obstetric Management Planning
Obstetric management planning is intrinsically linked to “how to calculate due date in IVF.” The accuracy of the estimated delivery date, established through precise dating methods in IVF, directly influences decisions regarding prenatal care, screening, and interventions. The due date serves as a crucial anchor point, guiding the timing of essential prenatal assessments, such as genetic screening, anatomy scans, and monitoring for pregnancy-related complications. An incorrect due date can lead to either premature or delayed implementation of necessary interventions, potentially impacting maternal and fetal outcomes. For example, if a due date is significantly overestimated, the timing of gestational diabetes screening might be delayed, increasing the risk of undetected and poorly managed hyperglycemia, which can have adverse effects on fetal development.
Effective obstetric management planning extends beyond merely scheduling appointments; it involves interpreting diagnostic results within the correct gestational age framework. Conditions such as intrauterine growth restriction (IUGR) and preterm labor are evaluated relative to the estimated due date. If the calculated delivery date is inaccurate, the interpretation of fetal growth patterns or contraction frequency may be flawed, leading to inappropriate management decisions. Furthermore, decisions concerning the mode of delivery, whether vaginal birth or Cesarean section, can be influenced by the gestational age assessment. For instance, elective induction of labor, typically considered around 39 weeks, necessitates accurate dating to minimize the risks of delivering a premature infant. The accuracy of the delivery date is especially critical in cases involving monochorionic twins, where the timing of delivery to prevent stillbirth needs a solid estimated date.
In conclusion, accurate dating in IVF, which is achieved by calculating the date with precision, is not merely a preliminary step; it is a fundamental component of comprehensive obstetric management planning. From scheduling prenatal screenings to managing potential complications and determining the optimal timing and mode of delivery, the estimated date exerts a profound influence on clinical decision-making. The integration of accurate dating into obstetric protocols improves the quality of care, optimizes maternal and fetal outcomes, and minimizes the risks associated with inaccurate gestational age assessment. Ongoing refinement of dating methods in IVF contributes directly to improved obstetric outcomes and reinforces the importance of precise calculations within the broader context of prenatal management.
9. Individualized Patient Factors
Individualized patient factors, while not directly altering the calculation of the estimated delivery date (EDD) in in vitro fertilization (IVF), significantly influence the interpretation and application of that date within the overall management of the pregnancy. The standardized formula for EDD calculation based on egg retrieval date and embryo transfer day provides a baseline. However, pre-existing maternal conditions, obstetric history, and specific characteristics of the IVF cycle necessitate a tailored approach that may prompt deviations from standard protocols or increased vigilance concerning potential complications. For instance, a woman with a history of recurrent pregnancy loss, even with a precisely calculated IVF due date, might warrant more frequent early ultrasounds or the continuation of certain medications beyond the typical timeframe. Such considerations stem from the individual’s risk profile, not from altering the foundational EDD calculation itself.
Consider the impact of maternal Body Mass Index (BMI) on ultrasound accuracy. Elevated BMI can reduce image clarity, potentially affecting the precision of early ultrasound measurements used to confirm or adjust the initial IVF due date. In such cases, healthcare providers might rely more heavily on the IVF dates or employ additional monitoring techniques. Similarly, women with pre-existing diabetes require stricter glycemic control throughout pregnancy. The calculated IVF due date becomes crucial for planning timely delivery interventions, as these patients may be at higher risk for stillbirth or macrosomia, necessitating a carefully managed delivery timeline aligned with accurate gestational dating. In multiple gestations achieved through IVF, delivery plans often deviate from singleton pregnancies. Individualized factors, like chorionicity and amnionicity, influence the timing of delivery, even with a precisely known EDD. Monochorionic twins, for example, require delivery earlier than dichorionic twins, irrespective of the calculated due date.
In conclusion, the standardized method of calculating the EDD in IVF offers a reliable starting point. Individualized patient factors, however, introduce layers of complexity that demand a holistic and tailored approach. These factors do not alter the calculation, but they substantially impact how the due date is interpreted, the frequency of monitoring, and the timing of interventions. Acknowledging the interplay between the standardized calculation and individual patient characteristics ensures optimal obstetric care, minimizing potential risks and maximizing positive outcomes in IVF pregnancies. The practical significance lies in recognizing that while the EDD calculation provides a foundation, successful management relies on a patient-centered strategy that adapts to the unique circumstances of each pregnancy.
Frequently Asked Questions
The following questions address common inquiries and concerns regarding the determination of the estimated delivery date in pregnancies achieved through in vitro fertilization (IVF).
Question 1: Is the calculation of the estimated delivery date more accurate in IVF pregnancies compared to natural conceptions?
Yes, the calculation generally exhibits greater accuracy in IVF pregnancies. In IVF, the date of egg retrieval, which closely approximates the date of fertilization, is precisely known. In contrast, natural conceptions rely on the last menstrual period, a less reliable marker due to variations in ovulation timing.
Question 2: How does the day of embryo transfer influence the calculation of the estimated delivery date?
The age of the embryo at transfer necessitates adjustments to the standard calculation. For a Day 3 transfer (three days after egg retrieval), 263 days are added to the egg retrieval date. For a Day 5 transfer (blastocyst stage), 261 days are added. This accounts for the in vitro development time.
Question 3: What role does early ultrasound play in refining the estimated delivery date after IVF?
Early ultrasound, typically performed between 6 and 10 weeks of gestation, validates the initial calculation based on IVF dates. Crown-rump length (CRL) measurements are used to assess gestational age. Significant discrepancies between the initial calculation and ultrasound findings necessitate adjustments to the due date.
Question 4: Can individual patient factors affect the reliability of the calculated due date in IVF?
Individual patient factors, such as maternal BMI, obstetric history, and pre-existing medical conditions, do not alter the calculation itself. However, they influence the interpretation and application of the due date in overall pregnancy management, potentially requiring more frequent monitoring or adjusted intervention strategies.
Question 5: What happens if there is a significant discrepancy between the due date calculated from IVF dates and that determined by early ultrasound?
Significant discrepancies warrant careful evaluation. Generally, a difference exceeding 5-7 days in the first trimester justifies adjusting the due date based on ultrasound findings. This adjustment ensures accurate timing of prenatal screenings and management of potential complications.
Question 6: Are there increased risks associated with miscalculating the due date in IVF pregnancies?
Yes. An inaccurate due date can lead to mistimed prenatal screenings, inappropriate management of pregnancy complications (such as preterm labor or post-term pregnancy), and potentially adverse outcomes for both mother and fetus. Accurate dating is essential for optimal obstetric care.
Accurate determination of the estimated delivery date in IVF is paramount for optimal prenatal care, informed decision-making, and improved maternal and neonatal outcomes. Integration of IVF dates and early ultrasound findings, coupled with consideration of individual patient factors, is essential for precise dating.
The next section will cover the steps needed to consider when the patient has a twin or triplet.
Tips for Accurate Due Date Calculation in IVF
Achieving precision in estimated delivery date determination following in vitro fertilization is paramount for optimal pregnancy management. The following guidelines enhance the accuracy and reliability of the due date calculation.
Tip 1: Meticulously Document Egg Retrieval Date: The egg retrieval date constitutes the foundation for all subsequent due date calculations. Accurate documentation of this date is non-negotiable. Verify the date with the IVF laboratory and patient records to ensure consistency.
Tip 2: Precisely Account for Embryo Transfer Day: The age of the embryo at transfer necessitates specific adjustments. If a Day 3 embryo is transferred, add 263 days to the egg retrieval date. For a Day 5 embryo, add 261 days. Document the transfer day clearly to avoid errors in subsequent calculations.
Tip 3: Prioritize Early Ultrasound Confirmation: An ultrasound examination between 6 and 10 weeks of gestation serves as a critical validation tool. Crown-rump length (CRL) measurements are used to determine gestational age. Discrepancies exceeding 5-7 days warrant adjusting the initial IVF-based due date.
Tip 4: Scrutinize Ultrasound Reports: Carefully review ultrasound reports for any indications of growth discrepancies. If fetal measurements consistently deviate from expected values based on the calculated due date, investigate potential underlying issues and adjust the due date accordingly.
Tip 5: Maintain Diligence Regarding Patient History: Pertinent medical and obstetric history may necessitate adjustments to standard protocols. Factors such as prior preterm labor, cervical insufficiency, or maternal medical conditions warrant heightened vigilance and potential modifications to the management plan, irrespective of the initial due date calculation.
Tip 6: Employ Appropriate Software and Calculators: Utilize validated obstetric calculators or software programs specifically designed for IVF pregnancies. These tools minimize the risk of manual calculation errors and ensure consistency in due date determination.
Tip 7: Cross-Reference Multiple Data Points: Avoid relying solely on a single data point. Corroborate the estimated delivery date with multiple sources, including IVF records, ultrasound reports, and patient recall, to enhance reliability and detect potential inconsistencies.
Accurate due date calculation in IVF pregnancies is a multidisciplinary effort that necessitates meticulous documentation, precise calculations, and vigilant monitoring. Adhering to these guidelines optimizes obstetric management and improves patient outcomes.
With these guidelines on accurate due date calculation now discussed, a future focus is recognizing the unique situations related to multiple babies.
Conclusion
The preceding discussion has detailed the methodology for establishing the estimated delivery date in pregnancies conceived via in vitro fertilization. Accuracy in this determination relies on integrating the precise egg retrieval date, accounting for the embryo transfer day, and validating these calculations with early ultrasound measurements. Failure to adhere to these principles introduces potential errors that can compromise the quality of prenatal care and influence obstetric management decisions.
Given the potential for complications and the necessity for timely interventions in IVF pregnancies, meticulous attention to accurate dating is paramount. Continued research and refinement of dating methods are warranted to further enhance the precision and reliability of estimated delivery dates, contributing to improved maternal and neonatal outcomes in this increasingly prevalent reproductive technology.
